New nosologies: atriogenic valvular regurgitation.

Area of Science:

• Cardiology
• Cardiac Surgery
• Heart Failure Research

Background:

• Functional mitral regurgitation (FMR) and functional tricuspid regurgitation (FTR) arise from cardiac remodeling with normal valve structures.
• Two primary mechanisms exist: ventricular phenotype (ventricular remodeling/dysfunction) and atrial phenotype (atrial remodeling/annulus dilatation).
• Both phenotypes are prevalent in heart failure patients, increasing morbidity and mortality, thus representing a key therapeutic target.

Purpose of the Study:

• To review the epidemiology of atrial functional regurgitation.
• To elucidate the pathophysiology of atrial functional regurgitation.
• To discuss the prognosis and therapeutic strategies for atrial functional regurgitation.

Main Methods:

• Literature review focusing on atrial functional regurgitation.
• Analysis of epidemiological data.
• Synthesis of pathophysiological mechanisms and clinical outcomes.

Main Results:

• Atrial functional regurgitation is a significant complication in heart failure.
• Atrial remodeling and annulus dilatation are key drivers.
• Understanding these mechanisms is crucial for targeted therapy.

Conclusions:

• Atrial functional regurgitation significantly impacts heart failure prognosis.
• Therapeutic strategies should address the atrial phenotype.
• Further research into targeted treatments is warranted.